michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Good morning, it's David. A big picture for 2022, I made brief reference to this previously. But our view of the earnings visibility and the growth visibility relative to 2022, essentially if you take the at least 10%, we underscore that with capital contribution to our EPS growth in line with our strategic target, which is 4% to 5%. So then if you back away from that, that leaves you 5% to 6% fundamental organic earnings growth contribution to get to the at least 10% number, and we think that's an appropriate and prudent an attractive outlook given the fluidity and dynamism of the marketplace. So broadly speaking, both components are in line with our long-term strategic objectives and we have a track record, including 2021, which is a disruptment of delivering in line with that. So good fundamentals. A little more than 50% of it being organic, a little less than 50% of it being capital deployment, and very much in line with our long-term strategic target.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Can't share a lot on the first quarter at this point. And believe me though, it's not because I don't want to, we've been working on this for a long time. We're really excited about the deal. We can't wait to share more with you in Q2. What I will share is, what I even shared a little bit to, Alex, is that, we have not seen any surprises since January, and that would make us feel differently about the numbers we shared at that point in time, which again, are still -- should be still on our website available. But we do have to finish running the traps, and put together the required accounting that's necessary to really provide more informed guidance. We hate to -- want to be a little bit ahead of ourselves now, only that slightly, or provide that at all a quarter from now. We just want to be prudent in our approach, and be as clear as possible with you and with the investors when the time is right.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
There are offsets. There is no question that if you look at medical economic data or actuarial data that, generally speaking, duration of membership causes acuity to decline -- the level of acuity to decline. There's no question about that. The longer they're on the roles, the less acute they are. Two factors, as you referenced offsets. One, many states took that into consideration in setting rates. So it's already in the rates that we have a lower acuity population. And second, bear in mind that while the volume won't get picked up by the risk corridors, any excess margin on those members is surely picked up by the risk corridors and 30% of our revenue is already in the 100% tier. So yes, I would look at -- there is a margin on those members, but the margin is likely no more than a low-single-digit target margin. But we view that as accreting off the books over a very long period of time in a very orderly fashion, as I suggested. But I -- the way we look at it is the margin on those members is no greater or less than the average margin of the portfolio.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Yes. I mean, it's a pretty consistent message, I think, that we get on and talk about each quarter, right? As far as M&A, we're always looking for what could be, I think, additive in different pieces of the business, right? And generally, what looks really attractive to us are sometimes a smaller, we use the word tuck-in, but sometimes are just smaller product acquisitions, right, or something that could really help the Table Games division or something that we look at that could be seemingly additive to like Interactive, whether it's another studio or something small, right?
As far as anything transformational, I wouldn't say that there's much in the way of that. But as far as other uses, I think you see us consistently reinvesting in the business through R&D. We're obviously putting money behind the premium and game ops initiatives, and we're very, very focused, I think, on the potential event next year, right, when our $95 million incremental rolls to 101 soft calls, like we look forward to being able to do something with that. And whether we refinance the entire term loan B structure or not, we'll see. But we're encouraged by conversations we've already had to-date. So we'll have very good options, we feel.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Morning. Question for Colin with regard to the Roomba combo. I was curious to know if you could give some additional color in terms of its performance in the quarter. And in general, your thoughts about combination robots at this point?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, the one that I would call out is credit in FICC just as an example, and I mentioned it earlier. So, this is where we saw a trend line developing around portfolio trading. And so, investments that we were making in platforms and technology capabilities and the like have served us well in the capture of a solid percentage of the portfolio trading and the volumes that are going through there. And so, that's an example of advancing and enhancing our technology capabilities that are in place. I'd also point out more generally that over the last couple of years, we've been spending quite a bit of money on straight-through processing. That is, taking note of the demands among our clients around middle and back office and the overall experience of our client set, not just on the front end of the trade, but all through to the back. Each of those investments, whether it's technology to build platforms that captures portfolio trading credit, or development of enhanced technology to automate and streamline the overall straight-through processing, all of that is subject to an ROI framework with an eye toward improving the overall client and user experience that's there. And so, that's just a little bit of insight into how we think about the investment and where we've been making that investment.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, if you look at the EBITDA margin, when we think about what's driving that, we've talked before about the Value Path initiative, which has various underlying multi-pads that we're running related to margin, SG&A, opex, et cetera. All of which is bringing that value that you are seeing as we can leverage the P&L. And then as we talked about for FY '22 and the go-forward for '22. We know we've got some of those headwinds that I mentioned, particularly the -- we looked at '22 as a transition year.
We've got some health and wellness, that'll be coming back if some rent for the Marino Valley side. We're losing the stabilized CSA contractually from a contract that's been pronounced there for years. We knew all of that was coming as we established those long-term targets. So when we think about EBITDA margin from '21 to '22, we know we've got those headwinds in '22, but we also know once we go through that transition year and get into '23 and '24, we're going to be right on track for those targets.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Just going back to the comments and the, I guess, the opening statements about RIDEA and having to add additional asset management. It almost sounds like you are a little bit hamstrung by the size of the Company. And so just -- once you complete all these restructurings, how do you think about the strategic size of the Company going forward? Do you need to be larger, so that you have more options and more arrows in the quiver going forward? Just want to get your thoughts on that. Thanks.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Jacob.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So first of all, I'll address the environment holistically, Todd, and Tom can give you a little bit more color around what I would call the tools in our toolkit. But the environment continues to be very vibrant. We're seeing a vast array of different types of sellers coming to market and we feel well-poised with the capacity of our balance sheet to continue to be a very efficient acquirer and we want to maintain that because we think it's highly advantageous even in a market like this, where it's quite competitive, depending on the type of asset and location, etc. that might come through. So we feel very well-poised, our balance sheet has been and will continue to be a great competitive advantage for us and we'll continue to, as I mentioned, look at many of the tools in our toolkit. So Tom can give you a little bit more color on that, but we're very confident we will continue to be able to embrace this environment with a whole range of different opportunities that may come through.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So Q3 would be -- again, since we're still determining exactly the amount. These are rough numbers. But Q3 would be somewhere in the 4.5% range, and then Q4 would be anywhere from -- it could be 4.5% to 5% in that range.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. And I guess more of a broad comment, Wamsi. I would say, Industrial is a very big market broadly and it will vary by vertical. And I think that's why you've seen each company because each company has a little bit different exposure in their customer base on the industrial side, some are growing faster than others. I think on average, if you look at the next few years, Industrial broadly is going to grow very nicely because I think COVID was immensely disruptive for them in terms of having, for example, their Asian supply chain shutdown and now on top of it, you've got shortages and logistics issues. So I do think broadly Industrial will be a strong grower in the next few years for everyone.
The individual rate by quarter will probably vary depending on what market you're really focused on. So I wouldn't worry too much about quarter-by-quarter changes. But if you look at year-over-year changes going forward, I think there will be a lift for most people participating in this space. And obviously, we tend to target the ones that are most technology-driven. Some of those will be faster growing than others coming out, but I think they all should be pretty impressive growth rates is my guess, if that's helpful to you.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Chris, the design of our distribution and what's happened out there is really part of the COVID playbook. So on the COVID playbook, we're tracking weekly access to the hospital's ICU capacity, Impella Connect and then we do see a flip back and forth between the high-risk PCI patients and the shock patients. We know if shock or pulmonary embolism or ECPella and those things go up, the ICUs fill up. That means that we're going to have a bit of a delay in high-risk PCI at the big centers, but that bolus will come back. The interesting element of that is our smaller and mid-sized territories and hospitals, they did not see that dip as much because they then potentially do that patient and they don't refer that patient to the larger center.
If we track on shock and you look at the year, six out of the 12 months had positive growth. Eight of the 12 months had flat to positive. And two -- the first two months of COVID last April, May were down and they were down double-digit. But after that, shock itself recovered, and that's kind of part of the playbook. And then in this hub-and-spoke piece of this, is, as we've mentioned, we set records in Q4. But in March, we set our records for most patients ever, most high-risk PCI patients ever and most cardiogenic shock patients ever. So we think the playbook works, and we like this hub-and-spoke network, and we like the changes we've made to the distribution to really capitalize on that opportunity.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I mean, I didn't know that the world existed west of the Hudson River. Is there something else out there? No. I think -- joking aside. The last thing we want to do is generate speculation.
I think as prudent fiduciaries to our stakeholders, as prudent investors, we really need to look at all things which -- that could be logical. And how we allocate our capital, we look forward to have something to talk about other than speculation and we'll be much more talkative as and when we do.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think a couple of things. I mean we are cash-heavy right now, on top of that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. The DOD IG audit, we look to have a rough draft this fall and a publication shortly thereafter. We still have not seen that but still anticipate -- and still, quite frankly, anticipate similar conclusions to prior audits. So that's what we see right now.
We have closely worked with the DOD, the IG, in regular weekly meetings to review information data and build a working group to continue to improve our relationship with the DOD and the important players on the defense side of the house. So that's what we know so far. But yeah, sometime this fall.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Don't forget, most of the people you mentioned are also our customers, first off first and foremost. And we enjoy great relationships with almost anybody in the field of proteomics. I think the core underlying growth level for just down the basic research is phenomenal.
I do think that avenues like Olink are high-plexing kind of different niche, high-value applications that drive a lot of value. And but I think we'll reach into those spaces as well to work with them and probably compete with them, but we'll never giving up our core and we'll king of the core in terms of antibodies and proteins for some

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I mean when you're growing at a 56% rate, I mean there's a lot more onboarding within your numbers than there is when you're growing at a projected 18% rates. I can't really give you a fixed number, but I mean if you look at the numbers really where they were probably at the start of this year where the operating margins were running, that's more in line with normal, both from a gross margin perspective. And the onboarding costs with the -- on the gross margin side really is more training where we typically do charge customers for their time training, but it's at a reduced rate. And so, that ends up bringing your margin down a little bit in the short term.
But longer term, we still expect to be in that 24, 25% operating margin on a -- or EBITDA margin, sorry, on an ongoing basis.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I would expect that actually to grow sequentially into the first half and then level off from there.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I mean, you nailed it right. So when China changes disproportionately as a percentage of net sales, either on year-over-year comps or sequentially, you're going to see a gross profit headwind. That gets made up in other parts of the P&L. So net-net from an OI perspective, it'll net out, but yes, as a percentage you'll see some headwind and that's effectively what we saw in Q2.
So you saw, if you look at the year-over-year gross profit coming down from where we were in 2020, that's largely because of mix, currency and pricing sort of offset each other. And that percentage came down because of the China mix. Overall from a profitability standpoint, if you look at our OI, you see OI increasing by about 40 to 50 basis points year-over-year. So overall, the profitability doesn't change from the net sales mix, but from an OI perspective, but from a gross margin perspective, it is. So I think you kind of nailed it, but that is an important distinction to make.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Sure. I think really as we looked at again -- and we're very pleased with the guidance that we're providing next year for double-digit growth next year on top of what was a phenomenal year this year, as you pointed out. So looking at that growth of 10% to 12%.
As we get into Q1, it's clearly our most difficult comparison quarter. But Bill, why don't you speak specifically to what we're seeing in the wholesale side of things. Some of that impacts Q1 but also moves into Q2.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, yeah, we are certainly gratified by our loan production in the fourth quarter. It was -- it was distributed though. Warehouse was the bulk of it, and it came from new relationships that we brought on. And as you know, we focus on meeting lower size mortgage brokers and not the huge guys, although we have some of those relationships as well. And we expect warehouse lending in terms of those balances to remain relatively flat for the year.
So there is a lot of volume in terms of moving in and out. But we think the level at which we're at is about right. But we also had $230 million of growth in other areas. And when you compare that to our overall loan portfolio, it was 3.8% on a quarterly basis, but it was about 15% annualized. And then if you look at our -- that $230 million across our loan portfolio, excluding warehouse, it was closer to 5% or 4.7% or 18% annualized.
So, I think we had a good distribution of loans. We had a good inflow of C&I. As we look at this quarter, we're starting to see pretty good inflow of CRE on the bridge side right now. All of our teams are working really hard and obviously we have the PPP that's in process right now. Early indications are that we're going to try to be somewhere where we were last time. We have about 500 -- almost 500 inquiries right now that are a little north of $100 million, loan sizes are a little bit smaller, but there is obviously the $2 million max in the program this year for the second round.

    Prediction (one of UP, DOWN, SAME): SAME